Memorial Sloan Kettering Cancer Center

A clinical experiment found that after six months of using a medication, 12 individuals with rectal cancer had no symptoms of tumor. The medicine Dostarlimab was used in trial at Memorial Sloan Kettering Cancer Center (MSKCC), New York. This is "the first time this has happened in the history of cancer," said Dr. Luis A. Diaz J., MSKCC. Researchers said the medicine seemed beneficial, but a larger-scale experiment is required.